Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosis for cancer patients. In the preclinical setting, Ras activation by mutation or EGFR amplification results in increased clonogenic cell survival and decreased tumor growth delay following irradiation...
Hlavní autoři: | Cengel, K, Mckenna, W |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2005
|
Podobné jednotky
-
Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
Autor: Cengel, K, a další
Vydáno: (2004) -
The influence of Ras pathway signaling on tumor radiosensitivity.
Autor: Kim, I, a další
Vydáno: (2004) -
Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
Autor: Muschel, R, a další
Vydáno: (2001) -
The clinical implications of gemcitabine radiosensitization.
Autor: Doyle, T, a další
Vydáno: (2001) -
Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
Autor: Kim, I, a další
Vydáno: (2005)